| Autor: |
Amir Khorrami, Sahil Kumar, BSc, MSc, Elise Bertin, BSc, Richard Wassersug, BSc, MSc, PhD, Cormac O'Dwyer, BSc, Smita Mukherjee, MS, PhD, Luke Witherspoon, MSc, MB, MD, Peter Mankowski, MSc, Krista Genoway, MD, FRCSC, Alex G. Kavanagh, MD, FRCSC |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Sexual Medicine, Vol 10, Iss 3, Pp 100505- (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2050-1161 |
| DOI: |
10.1016/j.esxm.2022.100505 |
| Popis: |
ABSTRACT: Background: Following metoidioplasty, transmen (TM) experience sexual function challenges including erectile dysfunction, which is typically treated in cisgender men with phosphodiesterase-5 inhibitors (PDE5i) and intracavernosal injections (ICI). Aim: We aim to evaluate sexual function post-metoidioplasty and explore attitudes toward using PDE5i and ICI as potential erectile aids Methods: All patients who had metoidioplasty completed at the Gender Surgery Program in Vancouver, British Columbia were contacted. Participants completed an electronically accessible self-constructed questionnaire consisting of 39 items on erectile function, orgasm, and penetrative intercourse which also captured Erection Hardness Scores (EHS). Data were analyzed via t-test and 1-way ANOVA. Outcomes: Our outcomes were the importance of erectile function, ability to orgasm, penetrative intercourse, and attitudes towards using PDE5i and ICI post-metoidioplasty. Results: Fifteen out of 22 patients completed the survey (median age 32 years). Most had metoidioplasty within the past 2 years. The participants ranked the ability to orgasm and to achieve or maintain erections significantly higher than penetrative intercourse (P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
